Cell Lysis/Cell Fractionation Market is Forecasted to Increase at a CAGR of 10.3%. - PowerPoint PPT Presentation

About This Presentation
Title:

Cell Lysis/Cell Fractionation Market is Forecasted to Increase at a CAGR of 10.3%.

Description:

Free view report synopsis @ . The major factors contributing to the growth of the cell lysis market include increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market. – PowerPoint PPT presentation

Number of Views:10

less

Transcript and Presenter's Notes

Title: Cell Lysis/Cell Fractionation Market is Forecasted to Increase at a CAGR of 10.3%.


1
Cell Lysis/Cell Fractionation Market by Product
(Consumables (Reagents, Enzymes, Detergent),
Instruments (Sonicator, Homogenizer)), Type of
Cell (Microbial, Mammalian), End User (Research
Laboratories, Biopharmaceutical Biotechnology
Companies) - Global Forecasts to
2021ByMarketsandMarkets
Published April-2016 Single User US
4650 Corporate User US 7150
  • Browse more reports on Market Research _at_
  • http//www.rnrmarketresearch.com/reports/life-scie
    nces .

2
Cell Lysis/Cell Fractionation Market Global
Forecasts to 2021.
  • The cell lysis market is expected to reach USD
    3.84 billion by 2021 from USD 2.35 billion in
    2016, at a CAGR of 10.3. The global cell lysis
    market is segmented based on product, type of
    cell, end-users, and regions. The consumables
    segment is expected to register the highest
    growth rate in the cell lysis market, byproduct,
    during the forecast period. The high growth in
    this segment is attributed to the increasing
    investments in research.
  • Based on end-users, the cell lysis market is
    segmented into research laboratories and
    institutes, biopharmaceutical and biotechnology
    companies, and others. The research laboratories
    and institutes segment is expected to account for
    the largest share of the market in 2016.
    Increasing prevalence of diseases and the need
    for development of new therapies will drive the
    growth of this market. Geographically, the cell
    lysis market is dominated by North America,
    followed by Europe, Asia, and the Rest of the
    World (RoW). Growth in the North American segment
    is primarily driven by increasing aging
    population, and rising government funding in the
    North American countries.

3

Cell Lysis/Cell Fractionation Market Global
Forecasts to 2021.
The major factors contributing to the growth of
the cell lysis market include increasing
government funding for research, high prevalence
of diseases, expanding biotechnology and
biopharmaceutical industries, and growing focus
on personalized medicine. Furthermore, increasing
RD spending and new product development
activities by companies is another major factor
driving the growth of this market. Apart from
comprehensive geographic and product analysis and
market sizing, the report also provides a
competitive landscape that covers the growth
strategies adopted by industry players over the
last three years. In addition, the company
profiles comprise the product portfolios,
developments, and strategies adopted by the
market players to maintain and increase their
shares in the market. The above-mentioned market
research data, current market size, and forecast
of the future trends will help key market players
and new entrants to make the necessary decisions
regarding product offerings, geographic focus,
change in strategic approach, and levels of
output in order to remain successful in the
market.
RnRMarketResearch.com sales_at_nrmarketresearch.
com 1 888 391 5441
4
Cell Lysis/Cell Fractionation Market Global
Forecasts to 2021.
  • The major players in this market include Beckman
    Coulter, Inc. (U.S.), Becton, Dickinson and
    Company (U.S.), Bio-Rad Laboratories, Inc.
    (U.S.), Cell Signaling Technology, Inc. (U.S.),
    F. Hoffman-La Roche AG (Switzerland), Merck KGaA
    (Germany), Miltenyi Biotec (Germany), QIAGEN N.V.
    (Netherlands), Qsonica, LLC. (U.S.), and Thermo
    Fisher Scientific Inc. (U.S.).
  • Complete report on Cell Lysis/Cell Fractionation
    Market spread across 135 pages, 10 profiling
    companies and supported with 84 tables and 41
    figures is now available at http//www.rnrmarketre
    search.com/cell-lysis-cell-fractionation-market-by
    -product-consumables-reagents-enzymes-detergent-in
    struments-sonicator-homogenizer-type-of-cell-micro
    bial-mammalian-end-user-research-laboratories-biop
    harmaceut-ts-to-2021-market-report.html .

5
Table of Contents 1 Introduction 2 Research
Methodology 3 Executive Summary 4 Premium
Insights 5 Market Overview 6 Cell Lysis Market,
By Product 
Cell Lysis/Cell Fractionation Market Global
Forecasts to 2021.
7 Cell Lysis Market, By Type of Cell 8 Cell
Lysis Market, By End User 9 Cell Lysis Market,
By Region 10 Competitive Landscape
Purchase a copy of this report http//www.rnrmar
ketresearch.com/contacts/purchase?rname523684 .
RnRMarketResearch.com sales_at_rnrmarketresearch
.com 1 888 391 5441
6
Cell Lysis/Cell Fractionation Market Global
Forecasts to 2021.
  • For more details contact Mr. Ritesh Tiwari
    sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.
Write a Comment
User Comments (0)
About PowerShow.com